Gilmore O'Neill is President and Chief Executive Officer of Editas Medicine, Inc. (EDIT). The company reported total compensation of $2,353,655 for fiscal year 2025.
| Salary | $686,574 |
|---|---|
| Bonus | $0 |
| Stock awards | $0 |
| Option awards | $1,282,937 |
| Non-equity incentive plan | $375,164 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $8,980 |
| Total | $2,353,655 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Editas Medicine, Inc. filed April 28, 2026, accession 0001650664-26-000037.
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Gilmore O'Neill this page | President and Chief Executive Officer | $2,353,655 |
| Linda Burkly | Executive Vice President and Chief Scientific Officer | $1,176,389 |
| Amy Parison | Senior Vice President and Chief Financial Officer | $821,655 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Editas Medicine, Inc. compensation brief.
Gilmore O'Neill's compensation sits inside Editas Medicine, Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.